These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6359795

  • 21. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H.
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the efficacy of three different treatments with imipenem versus the classical clindamycin plus tobramycin in experimental peritonitis.
    Gómez J, Ros J, Ruiz J, Canteras M, Valdés M, Martín-Luengo F.
    J Chemother; 1991 Dec; 3(6):367-71. PubMed ID: 1819619
    [Abstract] [Full Text] [Related]

  • 23. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
    Wilson SE.
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694
    [Abstract] [Full Text] [Related]

  • 24. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P, Thodis E, Eftimimiadou A, Panagoutsos S, Papazoglou D, Kaliengidou M, Kartali S, Vargemezis V.
    Adv Perit Dial; 1993 Feb; 9():206-10. PubMed ID: 8105925
    [Abstract] [Full Text] [Related]

  • 25. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W, Chylak J, Pietkiewicz K.
    Med Dosw Mikrobiol; 1996 Feb; 48(1-2):61-70. PubMed ID: 8926770
    [Abstract] [Full Text] [Related]

  • 26. [Antibacterial action of clindamycin in chronic, recurrent tonsillitis].
    Müller R, Wichmann G, Haufe E.
    Arzneimittelforschung; 1996 May; 46(5):534-8. PubMed ID: 8737642
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of mixed (aerobic/anaerobic) abdominal infections with clindamycin phosphate and gentamycin].
    Magistrelli P, Nuzzo G, Costamagna G, Coppola R, Masetti R, Murazio M, Puglionisi A.
    Minerva Chir; 1984 Mar 31; 39(6):411-4. PubMed ID: 6462499
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of cefuroxime and gentamicin in combination with metronidazole in the treatment of peritonitis due to perforation of the appendix.
    Saario I, Arvilommi H, Silvola H.
    Acta Chir Scand; 1983 Mar 31; 149(4):423-6. PubMed ID: 6351522
    [Abstract] [Full Text] [Related]

  • 29. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
    Lin WJ, Lo WT, Chu CC, Chu ML, Wang CC.
    J Microbiol Immunol Infect; 2006 Jun 31; 39(3):249-54. PubMed ID: 16783457
    [Abstract] [Full Text] [Related]

  • 30. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
    Birolini D, Moraes MF, de Souza OS.
    Chemotherapy; 1989 Jun 31; 35 Suppl 1():49-57. PubMed ID: 2659290
    [Abstract] [Full Text] [Related]

  • 31. The optimum duration of systemic antibiotic administration in the treatment of experimental peritonitis.
    Law D, Law C, Todd JK, Eiseman B.
    Aust N Z J Surg; 1977 Feb 31; 47(1):105-7. PubMed ID: 266901
    [Abstract] [Full Text] [Related]

  • 32. A comparative study of cefamandole versus gentamicin plus clindamycin in the treatment of documented or suspected bacterial peritonitis.
    Busuttil RW, McGrattan MA, Freischlag J.
    Surg Gynecol Obstet; 1984 Jan 31; 158(1):1-8. PubMed ID: 6362043
    [Abstract] [Full Text] [Related]

  • 33. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
    Sweet RL, Ohm-Smith M, Landers DV, Robbie MO.
    Am J Obstet Gynecol; 1985 Aug 01; 152(7 Pt 1):808-17. PubMed ID: 3895947
    [Abstract] [Full Text] [Related]

  • 34. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK, Hagelskjaer LH.
    Ugeskr Laeger; 1996 Apr 29; 158(18):2538-41. PubMed ID: 8686007
    [Abstract] [Full Text] [Related]

  • 35. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
    Pastorek JG, Faro S, Aldridge KE, Nicaud SK.
    South Med J; 1987 Sep 29; 80(9):1116-9. PubMed ID: 3306943
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
    Tong MK, Leung KT, Siu YP, Lee KF, Lee HK, Yung CY, Kwan TH, Au TC.
    J Nephrol; 2005 Sep 29; 18(2):204-8. PubMed ID: 15931649
    [Abstract] [Full Text] [Related]

  • 38. Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections.
    Henning C, Medén-Britth G, Frölander F, Karlsson J, Dornbusch K.
    Scand J Infect Dis; 1984 Sep 29; 16(3):297-303. PubMed ID: 6494811
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
    Rodríguez JR, Ramírez-Ronda CH, Nevárez M.
    Antimicrob Agents Chemother; 1985 Feb 29; 27(2):246-51. PubMed ID: 4039118
    [Abstract] [Full Text] [Related]

  • 40. Intraperitoneal micro-organisms and the severity of peritonitis.
    Schoeffel U, Jacobs E, Ruf G, Mierswa F, von Specht BU, Farthmann EH.
    Eur J Surg; 1995 Jul 29; 161(7):501-8. PubMed ID: 7488664
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.